Most Recent
Mastercard considered threatening Coles with losing its discounted interchange fees to rival Woolworths if the supermarket chain re-routed customer debit and credit transactions away from the payments giant, a trial judge has heard in the ACCC's misuse of market power case.
Three years after filing, the class actions against Hyundai and Kia are trying to pinpoint the defect at the heart of the cases, with the car manufacturers complaining that the newest pleading, which seeks to expand the claims to include an additional 380,000 vehicles, is still missing key details.
Epic Games has told a judge that Apple is treating Australian competition laws with “arrogant disrespect” and urged him to order injunctions after he found the tech giant engaged in anti-competitive conduct in the app marketplace.
Apple and Epic Games are back in court for a high-stakes fight over the orders a judge should make following his finding that the company engaged in anti-competitive conduct in the app marketplace.
Mastercard's APAC head was "perfectly comfortable" with the threat of removal of discounted interchange rates to cut a deal with Coles to route transactions through its payment network, a court has heard.
The prevailing applicants in a contest to run class actions against Hyundai and Kia want all their costs of the beauty parade against the plaintiffs and funders of the failed cases, arguing the whole of their outlay was unnecessary.
Was inflation at work, or deception, when Woolworths' advertised the Oreo Family Pack as a 'Prices Dropped' special of $4.50 in December 2022, when the biscuits had been selling for $3.50 just three weeks earlier?
A class action over alleged flammable Vitrabond building cladding has secured an adjournment until after a court hears from the parties in an unsuccessful case against Alucobond maker 3A.
A judge has hit mattress retailer Emma Sleep with a $15 million penalty after it admitted to repeatedly misleading consumers about discounts, saying the ACCC's proposed $36 million was not needed to achieve deterrence.
US drug maker Pfizer has been hit with a class action alleging it knew or ought to have known about the increased risk that patients who used its injectable contraceptive Depo-Provera could develop brain tumors.